Linda Dejmek OD in Neenah, Wisconsin

Home Wisconsin Neenah

Linda Dejmek OD has Optometry as her primary medical specialty. Their primary office is: 1401 Mcmahon Rd in Neenah, Wisconsin. There is an additional office location, for a total of two, for Linda Dejmek OD that can be viewed further down. They attended Indiana University - School Of Optometry and graduated in 1977 (around 47 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Linda M Dejmek OD Office Phone and Directions

Linda Dejmek OD
1401 Mcmahon Rd
Neenah, Wisconsin 54956
920-722-2020

Patient Ratings
Please rate your experience with Linda Dejmek OD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 920-722-2020

Enter a starting address:

Healthcare Info for Linda Dejmek OD

Medical School: Indiana University - School Of Optometry
Graduation Year: 1977
The Primary Medical Specialty for Linda Dejmek OD is listed as: Optometry
Credentials: OD
Additional Credentials:
Approximate Years of Experience: 47
PAC (PECOS ID)#: 7618936782
NPI #: 1144286451
NPI Created On: 04/25/2006
NPI Last Updated Listed as: 03/13/2013
Primary Taxonomy Code: 152W00000X
License Number:
1576
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
Measurement of eye muscles to detect deviation of eyeball
Exercises to correct eyeball muscle imbalances

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792749949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DRY EYE

Name of Drug #1: RESTASIS MULTIDOSE

Open Associated Drug #1: 0023-5301-05